Hervé Maisonneuve

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 707 citations · Full text

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Emmanuel Gyan, Charles Foussard, Philippe B. Bertrand et al. · Blood · 2008 · 153 citations

Nitazoxanide in the Treatment of Taenia Saginata and Hymenolepis nana Infections

Jean François Rossignol, Hervé Maisonneuve · American Journal of Tropical Medicine and Hygiene · 1984 · 133 citations

Antiparasitic Agent, Medicine, T. Saginata +5

CD38 expression and secondary 17p deletion are important 
prognostic factors in chronic lymphocytic leukaemia

Patrice Chevallier, Dominique Penther, Hervé Avet‐Loiseau et al. · British Journal of Haematology · 2002 · 126 citations

Hematological Malignancy, Lymphoid Neoplasia, Chronic Lymphocytic Leukaemia +15

The Lymphoid Variant of Hypereosinophilic Syndrome

Guillaume Lefèvre, Marie‐Christine Copin, D. Staumont‐Sallé et al. · Medicine · 2014 · 121 citations · Full text